Donna R. Rivera
Scientific Project Officer
National Cancer Institute
National Institutes of Health
Donna Rivera joined the Surveillance Informatics Branch of the Surveillance Research Program as a Scientific Project Officer in 2016. She works on projects which enhance the availability and quality of treatment data within SEER through various external collaborations, including evaluation of novel methodologies for treatment capture. Her research focuses on the use of pharmacoepidemiology and pharmacosurveillance to evaluate medication utilization and health outcomes across the changing cancer treatment landscape, with an emphasis on immunotherapies, targeted therapies, and vaccines.
She earned her Doctor of Pharmacy degree from the University of Florida College of Pharmacy in Gainesville, Florida. Donna is a licensed pharmacist. Donna also earned her Master of Science in Pharmaceutical Sciences with a concentration in Pharmaceutical Outcomes and Policy and Pharmacoepidemiology from the University of Florida. She received her Bachelor of Science in Public Health from the University of South Florida.
Prior to SRP, Donna worked in the Clinical and Translational Epidemiology Branch (CTEB) of the Epidemiology and Genomics Research Program (EGRP) as a Program Director. Prior to NCI, Donna worked on Phase I clinical trials at Stiefel, a GlaxoSmithKline company.